Primary prevention of coronary heart disease: integration of new data, evolving views, revised goals, and role of rosuvastatin in management. A comprehensive survey

R Kones - Drug design, development and therapy, 2011 - Taylor & Francis
A recent explosion in the amount of cardiovascular risk and incipient, undetected subclinical
cardiovascular pathology has swept across the globe. Nearly 70% of adult Americans are …

Is prevention a fantasy, or the future of medicine? A panoramic view of recent data, status, and direction in cardiovascular prevention

R Kones - Therapeutic Advances in Cardiovascular Disease, 2011 - journals.sagepub.com
Americans are under assault by a fierce epidemic of obesity, diabetes, and cardiovascular
disease, of their own doing. Lowered death rates from heart disease and reduced rates of …

A multicenter, prospective, randomized, double-blind study to evaluate the safety and efficacy of saroglitazar 2 and 4 mg compared to pioglitazone 45 mg in diabetic …

V Pai, A Paneerselvam… - Journal of diabetes …, 2014 - journals.sagepub.com
Background: Dual PPARα/γ can improve both metabolic effects and minimized the side
effects caused by either PPARα or PPARγ agonist. The PRESS V study was aimed to …

Efficacy and safety of saroglitazar in patients with cardiometabolic diseases: a systematic review and meta-analysis of randomized controlled trials

DR Durga, N Mounika, P Mudimala, R Adela - Clinical Drug Investigation, 2022 - Springer
Abstract Background and Objective The incidence of cardiometabolic diseases is increasing
because of an increase in the standard of living. Currently, clinical treatment strategies for …

A reappraisal of the risks and benefits of treating to target with cholesterol lowering drugs

VM Alla, V Agrawal, A DeNazareth, S Mohiuddin… - Drugs, 2013 - Springer
Atherosclerotic cardiovascular disease (CVD) is the number one cause of death globally,
and lipid modification, particularly lowering of low density lipoprotein cholesterol (LDLc), is …

Importance of measuring non-HDL cholesterol in type 2 diabetes patients.

N Ram, B Ahmed, F Hashmi… - JPMA. The Journal of the …, 2014 - ecommons.aku.edu
OBJECTIVE: To study the correlation between Non-high-density lipoprotein and low-density
lipoprotein cholesterol in patients with Type 2diabetes mellitus and the proportion of patients …

[PDF][PDF] 非高密度脂蛋白胆固醇的临床意义及其在儿科中的应用

陈联辉, 施锡锋, 梁黎 - 2013 - researchgate.net
随着社会的快速转型和经济的迅速发展, 营养过剩等导致的儿童青少年血脂异常问题日益凸显,
以肥胖, 高血糖, 高血脂及高血压为特征的代谢综合征的患病率也逐年上升⋯ …

[PDF][PDF] Low-fat versus low-carbohydrate diets, weight loss, vascular health, and prevention of coronary artery disease: the evidence, the reality, the challenge, and the …

R Kones - Nutrition in Clinical Practice, 2010 - researchgate.net
Low-Fat Vs Low-Carbohydrate Diets/Kones 529 permit them to continue their unhealthy
habits in order to avoid making the necessary fundamental changes. In part, the media fuels …

Study of Non-HDL Cholesterol Level in Adult Patients Attending Rural Tertiary Care Hospital Chengalpattu District

JJS Weizman, V Santhosh, AK Bi, C Rexy - Cardiometry, 2022 - search.proquest.com
INTRODUCTION: Disease of the coronary artery is pivotal and accounts to high incidence of
morbidity and mortality world over. Research have shown its impact on the economy which …

[PDF][PDF] IN VITRO ANTI-ATHEROGENIC EFFECTS OF ASIATIC ACID IN HUMAN AORTIC ENDOTHELIAL CELLS

FLAI YEN - 2016 - psasir.upm.edu.my
Statins are inhibitors of 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase and it
serves as a primary approach used to prevent and treat atherosclerosis. However, long-term …